Corgenix Announces Issuance Of European Patent For Aspirin Resistance Testing

Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, has received notification of European Patent Office (EPO) approval for technology to which Corgenix holds exclusive worldwide licensing rights. McMaster University (McMaster) of Hamilton, Ontario, is the owner of the patent covering the aspirin resistance measurement method.

More: continued here

Filed under: Medical Devices on February 26th, 2008